Effects of cardiac glycosides on atrial fibrillation.
Veloso
H H
HH
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004285:Dogs; D013327:Strophanthidin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D013327:Strophanthidin; C004681:acetylstrophanthidin